AGEN Agenus Inc

Price (delayed)

$6.33

Market cap

$284.98M

P/E Ratio

2.39

Dividend/share

N/A

EPS

$2.65

Enterprise value

$556.41M

?
Relative Growth: Rel. Growth: 73
Relative Strength: Rel. Strength: 92
Relative Valuation: Rel. Valuation: 97
Relative Profitability: Rel. Profitability: 83

Agenus is a leading immuno-oncology company targeting cancer with a comprehensive pipeline of immunological agents. The company was founded in 1994 with a mission to expand patient populations benefiting from ...

Highlights
AGEN's net income has soared by 156% YoY and by 42% QoQ
The EPS has surged by 138% year-on-year and by 60% since the previous quarter
The quick ratio has decreased by 9% from the previous quarter

Key stats

What are the main financial stats of AGEN

AGEN stock price

How has the Agenus stock price performed over time
Intraday
-2.76%
1 week
4.8%
1 month
-24.64%
1 year
51.44%
YTD
101.59%
QTD
-36.25%

Financial performance

How have Agenus's revenue and profit performed over time
Revenue
$132.69M
Gross profit
$132.05M
Operating income
$35.88M
Net income
$92.01M
Gross margin
99.5%
Net margin
69.3%
AGEN's net income has soared by 156% YoY and by 42% QoQ
Agenus's net margin has surged by 143% YoY and by 33% QoQ
AGEN's operating income has surged by 139% year-on-year
AGEN's operating margin has soared by 130% YoY

Price vs fundamentals

How does AGEN's price correlate with its fundamentals

Growth

What is Agenus's growth rate over time

Valuation

What is Agenus stock price valuation
P/E
2.39
P/B
N/A
P/S
1.97
EV/EBIT
3.68
EV/EBITDA
3.57
EV/Sales
4.19
The EPS has surged by 138% year-on-year and by 60% since the previous quarter
AGEN's equity is up by 44% YoY and by 10% QoQ
The stock's price to sales (P/S) is 103% more than its last 4 quarters average of 1.0 but 19% less than its 5-year quarterly average of 2.5
Agenus's revenue has increased by 30% YoY and by 7% from the previous quarter

Efficiency

How efficient is Agenus business performance
Agenus's return on assets has surged by 157% YoY and by 45% QoQ
Agenus's ROIC has soared by 111% YoY but it has decreased by 18% from the previous quarter
The return on sales is up by 16% since the previous quarter

Dividends

What is AGEN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AGEN.

Financial health

How did Agenus financials performed over time
AGEN's total assets is 54% lower than its total liabilities
AGEN's total liabilities is down by 27% YoY and by 9% from the previous quarter
Agenus's current ratio has decreased by 11% QoQ
AGEN's equity is up by 44% YoY and by 10% QoQ
The debt to equity has declined by 6% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.